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Aging is accompanied by a decrease in several physiological func-
tions that make older individuals less responsive to environmental
challenges. In the present study, we analyzed the immune response of
female BALB/c mice (N = 6) of different ages (from 2 to 96 weeks)
and identified significant age-related alterations. Immunization with
hapten-protein (trinitrophenyl-bovine serum albumin) conjugates re-
sulted in lower antibody levels in the primary and secondary responses
of old mice (72 weeks old). Moreover, young mice (2, 16, and 32
weeks old) maintained specific antibodies in their sera for longer
periods after primary immunization than did old mice. However, a
secondary challenge efficiently induced memory in old mice, as
shown by the increased antibody levels in their sera. The number of
CD4+ and CD8+ T cells in the spleen increased until 8 weeks of age but
there was no change in the CD4+/CD8+ ratio with aging. Splenic T
cells from old mice that had or had not been immunized were less
responsive to concanavalin-A and showed reduced cytokine produc-
tion compared to young mice (IL-2: 57-127 vs 367-1104 pg/mL, IFN-
γ: 2344-12,836 vs 752-23,106 pg/mL and IL-10: 393-2172 vs 105-
2869 pg/mL in old and young mice, respectively). These data suggest
that there are significant changes in the organization of the immune
system throughout life. However, the relevance of these alterations for
the functioning of the immune system is unknown.
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• T cell response
• T cell subsets
Introduction
The aging process is associated with a
variety of changes in the physiology of an
organism and, although no universally rec-
ognized senescent marker has been identi-
fied (1-3), various promising candidates have
been suggested, including total serum gluta-
thione concentration as an accessible index
of longevity (4) and oxidative DNA damage
as a marker of cellular aging (for reviews,
see Refs. 1 and 3).
Many studies of the effects of aging on
the immune system have been carried out in
humans or in rodent models, highlighting
changes in both the cellular and humoral
immune responses. Thus, the aging process
has been associated with a reduction in B and
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T cell responsiveness to a variety of anti-
gens, a fact that may contribute to the sig-
nificant increase in the incidence of infec-
tious diseases observed in older individuals
(5-7).
The aging process is marked by func-
tional impairment of the antibody response
in both mice and humans (6). The aged
immune system usually generates antibodies
with a lower avidity compared to the system
of younger individuals (5,8). The capacity to
mount a primary humoral response is also
reduced during aging (8-12). In aged mice,
bone marrow functions as a late antibody
production site, although the numbers of
antibody-forming cells are reduced compared
to younger animals, a fact that is related to
the reduced primary response (13). The ag-
ing process also affects the repertoire and
diversity of B cells (14).
T cell-mediated immunity is a multifac-
torial phenomenon affecting T cell subset
composition as well as lymphocyte prolif-
eration and cytokine production along the
pathway of T cell activation. However, it has
been shown that aging decreases T cell pro-
liferation and IL-2 production in both hu-
mans and experimental models (for reviews,
see Refs. 7 and 15), although a few discrep-
ant experiments showed no change or an
increase in IL-2 production in response to a
mitogen in old subjects (for reviews, see
Ref. 7). Some reports have shown that leu-
kocytes of aged mice present an increase in
IL-4 secretion as well as a decrease of IL-2
production, thus indicating a shift to the TH2
responses due to age (for reviews, see Refs.
15 and 16-19).
Although aging seems to affect the pro-
portions of peripheral CD4 and CD8 T cells
as well as T cell functions in mice and hu-
mans, literature data concerning these mat-
ters are conflicting (17,20-25). Some reports
have shown a decline in CD8 T cells in
spleen, but not in gut-associated lymphoid
tissue in humans, while no alteration in CD4
T cells was found (24). However, Callahan
and collaborators (20) reported a decrease in
the CD4/CD8 ratio in mice as they aged,
reflecting a significant decrease in CD4 T
cell numbers and only a slight decrease in
CD8 T cells (20).
Although the knowledge of T cell func-
tion and activation has greatly improved on
the last decade, the question of whether dif-
ferences between young and old individuals
are due to altered T cell subset composition
has not been properly answered. In addition,
many studies on aging are carried out using
specific points in mice development, arbi-
trarily defined as young or old. Since many
factors may be involved, we organized a
systematic study of the effects of aging on
the immune system of rodents, simulta-
neously considering the main aspects of the
adaptive immune response of both naive and
immunized BALB/c mice at various stages
of postnatal development, including serum
antibody levels, concanavalin-A (Con-A)-
induced T cell proliferation, production
of cytokines by mitogen-activated spleen




Two- or four-week-old female BALB/c
mice were supplied by the Multi-Institu-
tional Center for Biological Investigation
(CEMIB) of the State University of Campi-
nas, Campinas, Brazil. The mice were housed
under pathogen-free conditions and received
a diet of autoclaved food and water. The
University Committee for Ethics in Animal
Experimentation approved this study (No.
912-1).
Reagents
Type V bovine serum albumin (BSA),
type VI ovalbumin (OVA) and 2,4,6-trini-
trobenzenesulfonic acid were purchased from
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Sigma (St. Louis, MO, USA). Trinitrophenyl-
BSA (TNP-BSA) and TNP-OVA were pre-
pared as described elsewhere (26,27, respec-
tively). mrIL-4 and mrIFN-γ were purchased
from Genzyme (Cambridge, MA, USA) and
Genentech Inc. (South San Francisco, CA,
USA), respectively. The monoclonal anti-
CD4 and anti-CD8 antibodies (mAbs) con-
jugated with fluorescein isothiocyanate
(FITC) and anti-CD3 conjugated with phy-
coerythrin were purchased from PharMingen
(San Diego, CA, USA).
Immunization
Mice were immunized intraperitoneally
with 100 µg TNP-OVA conjugate and
Freund’s complete adjuvant (FCA) (1:1, v/
v). On day 28, some of the mice had this
immunization boosted with an additional
100 µg TNP-OVA diluted in 0.15 M saline
solution. The mice were bled monthly and
the sera used for measuring antibody pro-
duction. Zero, 14, 28, and 60 days after the
first immunization, mice were sacrificed in a
CO2 chamber and their spleens were isolated
aseptically.
Antibody assays
Titers of TNP-BSA and TNP antibodies
were determined by standard ELISA using
an automatic ELISA reader (Multiskan II,
MS, Labsystem, Helsinki, Finland). Micro-
titer plates (Falcon, BD Bioscience, Franklin
Lakes, NJ, USA) were coated with either
TNP-BSA or TNP-OVA by adding 50 µL
protein solution (10 µg/mL in carbonate/
bicarbonate buffer, pH 9.6) to each well, and
incubating the plates overnight at 4ºC. The
wells were washed with phosphate-buffered
saline (PBS) solution containing 0.05%
Tween 20 and then blocked with 5% (w/v)
skim milk in PBS for 1 h at 37°C. After
washing with PBS containing 0.05% Tween
20, the plates were incubated for 1 h at 37°C
with mouse anti-serum diluted in PBS from
1:100 to 1:12,800, washed again and incu-
bated with rabbit anti-mouse immunoglobu-
lin antibodies (275 ng/mL) for 1 h at 37°C.
The plates were washed again, and 50 µL of
a freshly prepared substrate chromogen
(0.03% H2O2 and 0.04% ortho-phenylenedi-
amine in 50 mM citric acid/di-sodium hy-
drogen phosphate buffer, pH 5.5) was added
to each well. After 30 min in the dark, the
reaction was stopped by adding 25 µL 4 N
H2SO4 to the wells, and absorbance was read
at 492 nm. ELISA scores were computed for
individual mice by summing the absorbances
of progressively more diluted serum. Data
are reported as means ± SEM for 5 mice in
each group (28).
Spleen cell culture
The spleens from individual mice were
aseptically collected and the cells were ho-
mogenized with a grinder in RPMI 1640
medium (Sigma) supplemented with 10%
fetal calf serum (FCS; Nutricell; São Paulo,
SP, Brazil), sodium bicarbonate (2 g/L),
HEPES buffer (2 g/L) and 2-mercaptoetha-
nol (2 µL/L). After incubation for 4 min with
lysis solution (NH4Cl, KHCO3, and EDTA)
at room temperature, cells were pelleted at
200 g for 10 min. The cells were then sus-
pended in RPMI 1640 with 10% FCS and
assayed for proliferation, cytokine produc-
tion and phenotype determination.
Mitogenic response
Proliferation assays were performed in
96-well tissue culture plates (Corning Co.,
Cambridge, MA, USA). Spleen cells were
seeded at a density of 2 x 105/well in RPMI
1640 supplemented with 10% FCS and cul-
tured in the presence of Con-A (2.5 µg/mL,
Sigma) in a 5% CO2 atmosphere at 37°C.
Three days later, 10 µL of a 5 mg/mL 3-[4,5-
dimethyltiazol-2-yl] diphenyltetrazolium
bromide solution (Sigma) was added to each
culture, and plates were incubated for an
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additional 4 h. To dissolve formazan crys-
tals, 10 µL 10% sodium dodecyl sulfate
(Bio-Rad Laboratories, Inc., Hercules, CA,
USA) was added to each well, and plates
were incubated overnight at 37°C. Absorb-
ance was determined with an automatic
ELISA reader (Multiskan II), at 540 nm and
used to indicate T cell proliferation (28).
Cytokine measurement
For cytokine determination, cell suspen-
sions were placed in 24-well tissue culture
plates (Corning) at a density of 2.5 x 106
cells/well in RPMI-10% FCS and stimulated
with 2.5 µg/mL Con-A. After 72 h of incuba-
tion, the culture supernatants were collected,
and ELISA was used to quantify cytokine
levels. IL-2 and IL-10 measurements were
carried out with commercial kits according
to manufacturer instructions (Mouse Inter-
leukin-2 ELISA kit (Intertest-2X) from Gen-
zyme Immunologicals, Cambridge, MA,
USA and Mouse Interleukin-10 ELISA kit
from Endogen Pierce Biotechnology, Rock-
ford, IL, USA). The assays for the detection
of IL-4 and IFN-γ used pairs of specific
mAbs prepared in our laboratory, and were
carried out as described elsewhere (29).
Flow cytometry analysis
Anti-CD4/FITC, anti-CD8/FITC and
anti-CD3/phycoerythrin were used to stain
spleen cells obtained from naive mice of
different ages, as described elsewhere (28).
Briefly, mAbs or isotype controls were added
to polystyrene tubes containing 1 x 106 spleen
cells, which were incubated at 4°C for 40
min. Cells were washed with PBS and sus-
pended with PBS containing 1% formalde-
hyde. Preparations were analyzed with a
FACScan flow cytometer using Cell Quest
software (BD Bioscience). For subset analy-
sis, the populations with forward and side
light scatter characteristics of lymphocytes
were gated initially.
Statistical analysis
The two-tailed Student t-test was used to
compare the different experimental groups,
with the level of significance set at P < 0.05.
Results
In vivo primary and secondary antibody
responses in BALB/c mice
Primary antibody responses were deter-
mined in mice aged 2, 16, 32, and 72 weeks.
All mice were injected intramuscularly with
one dose of TNP-BSA emulsified in 50%
FCA. ELISA was used to monitor increases
of specific antibodies in the sera, which were
collected weekly from all groups of mice
until 48 weeks after the challenge or natural
death. The results of these experiments are
presented in Figure 1. Maximum levels of
antibodies against TNP-BSA were observed
about 4 to 8 weeks after antigen administra-
tion. Mice immunized at 16 weeks of age
(adults) presented the highest antibody lev-
els. The oldest mice (72 weeks at immuniza-
tion) presented the greatest reduction in the
levels of antibodies against TNP-BSA con-
jugate (panel A). Similarly, the production
of anti-TNP antibodies was more elevated in
young than in old mice (panel B).
The secondary humoral immune response
was evaluated in the sera of mice that had
received a booster of TNP-BSA in the ab-
sence of an adjuvant 28 days after the pri-
mary challenge with the antigen. All groups
of mice showed a secondary response against
TNP-BSA, as revealed by higher ELISA
scores. These scores peaked 4 weeks after
the second challenge (Figure 1, panel C).
Mice immunized at 72 weeks of age pre-
sented the lowest levels of secondary re-
sponse. Once again, sera from the mice ini-
tially immunized at 16 weeks of age main-
tained the highest scores for antibodies
against TNP-BSA (panel C). The secondary
antibody response against TNP followed the
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same pattern as that observed for the pro-
tein-hapten complex (panel D).
Proliferative response and cytokine production
Spleens were collected from BALB/c
mice of different ages at day 0 (naive), 14,
28 (primary response), or 60 (secondary re-
sponse) after immunization with TNP-BSA.
Cells were stimulated with Con-A and the
proliferative response was measured 72 h
later by a colorimetric assay. Figure 2 sum-
marizes the results obtained in these experi-
ments. Spleen cells from naive or immu-
nized mice proliferated significantly in re-
sponse to Con-A. Spleen cells from young
mice (2 and 4 weeks of age) immunized with
TNP-BSA were more responsive to Con-A
than cells from naive mice (P < 0.05). In
contrast, cells from old mice (48 and 72
weeks of age) collected at 28 and 60 days
after immunization were the least respon-
sive to Con-A stimulation (P < 0.05). Cells
from adult mice (16 and 32 weeks old) dis-
played a similar proliferative response to
Con-A, regardless of treatment.
The secretion of TH1 (IL-2 and IFN-γ) and
TH2 (IL-4 and IL-10) cytokines was meas-
Figure 1. Effect of aging on antibody levels in the sera of BALB/c mice. Sera were collected monthly for 12 months or until natural death from mice (N
= 5) of different ages, which were immunized with one (primary response; panels A and B) or two (secondary response; panels C and D) doses of
trinitrophenyl-bovine serum albumin (TNP-BSA). The arrows in panels C and D indicate the administration of the challenge dose. Antibody titers to
TNP-BSA and TNP were determined by ELISA using TNP-BSA (panels A and C) or TNP-ovalbumin (panels B and D) as coating proteins, respectively.
Antibody levels are reported as the mean ± SEM of individual running sums of absorbance readings for serum dilutions of 1:100 to 1:12,800.
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Figure 2. Influence of age on T
cell proliferation. Spleen cell of
BALB/c mice of different ages
were collected 0, 14, 28 or 60
days after immunization with
trinitrophenyl-bovine serum al-
bumin and cultured for 72 h in
the presence of concanavalin-A
(2.5 µg/mL). Proliferation was
measured by the diphenyltetra-
zolium bromide-staining assay,
in six replicates, with spleen
cells pooled from 3 to 6 mice.
The baseline represents T cells
cultured in the absence of con-
canavalin-A. Data are reported
as mean ± SEM absorbance at
540 nm and are representative
of three independent experi-
ments. *P < 0.05 compared to
their respective naive group
(Student t-test).
Figure 3. Cytokine levels in the
supernatant of concanavalin-A-
stimulated spleen cells from
aged mice. Mice were immu-
nized with trinitrophenyl-bovine
serum albumin at different ages
and their spleens were collected
0, 14, 28, or 60 days after anti-
gen injection. Cell suspensions
of each group of mice were
pooled and seeded in six repli-
cates and then cultured in the
presence of concanavalin-A (2.5
µg/mL) for 72 h. The levels of
interleukin-2 (IL-2; panel A), in-
terferon-γ (IFN-γ; panel B), IL-4
(panel C), and IL-10 (panel D)
were measured by ELISA in the
pooled culture supernatants.
Data are reported as mean ±
SEM cytokine concentrations
and are representative of two in-
dependent experiments. *P <
0.05 compared to their respec-
tive naive group (Student t-test).
ured in the supernatants of the Con-A-stimu-
lated spleen cells (Figure 3). IL-2 secretion
was detected in the supernatants of Con-A-
stimulated cells of neonate (2 weeks old),
young (16 weeks old) and adult (32 weeks old)
mice, but not in the supernatants of the oldest
animals (Figure 3A). Con-A-stimulated IFN-γ
secretion increased in the supernatants of cells
obtained from immunized mice as a function
of time of immunization and animal age up to
32 weeks of age, decreasing thereafter in the
oldest group (Figure 3B).
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IL-4 and IL-10 levels in the supernatants
of spleen cell cultures of naive mice also
increased significantly with age up to 32
weeks (Figure 3C,D). The levels of IL-4 and
IL-10 in the culture supernatants of cells
harvested 14 days after immunization in-
creased significantly over those obtained in
the supernatants of naive cells for all ages
(Figure 3C,D). IL-4 and IL-10 levels did not
increase in the supernatants of spleen cells
collected 28 days after immunization com-
pared to those detected in the supernatants of
naive cells, except in the oldest group, in
which these levels were sustained. No sig-
nificant difference was observed in the su-
pernatants of spleen cells collected 60 days
after immunization.
T cell population profiles
To determine putative age-related alter-
ations in T cell frequency, the spleen cells of
naive BALB/c mice aged 2 to 96 weeks were
examined by flow cytometry using double
staining with anti-CD3 and anti-CD4 or anti-
CD8 antibodies; the results are shown in
Figure 4. The percentage of CD4+ and CD8+
T cells increased significantly up to eight
weeks of age (7.28-25.88% for CD4+; 3.38-
14.88% for CD8+), remaining unchanged
Figure 4. Age-related changes in T cell profile. Cells were collected from spleen of naive BALB/c mice at various ages, and labeled with anti-CD3, anti-
CD4 and anti-CD8 antibodies. Panel A, Representative example of cytofluorimetric analysis (the numbers inside the plots indicate the mean
percentages of double-positive T cells). Panel B, Data are reported as median of individual percentages of spleen cells expressing CD3+CD4+ or
CD3+CD8+. Panel C, CD4/CD8 T cell percentage ratios. The assays were carried out in triplicate and data are representative of three separate
experiments.
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thereafter. No significant changes in CD4+/
CD8+ ratio were observed with aging.
Discussion
The aging process affects both the hu-
moral and cell-mediated immune responses,
a situation that has been blamed for the high
incidence of infectious and tumoral illnesses
in older individuals. It has been shown that
aging provokes changes in the capacity to
mount a primary immune response, with
older individuals being less responsive to
the antigens used for primary immunization
(8,10,11,30), although the secondary re-
sponse is thought not to undergo a signifi-
cant change with age (11).
Most of the research on age-related alter-
ations in the immune system has investi-
gated the process at specific times during the
lifetime, with subjects being arbitrarily de-
fined as young or old. The absence of criteria
for the definition of age groups may, thus, be
one cause of the conflicting interpretations.
Some reports have suggested that senes-
cence marker protein-30 can be used as a
specific marker for aging (31-33). This pro-
tein, expressed by hepatocytes, pulmonary
and renal cells in rats and mice, gradually
decreases with age (33,34).
In the present study, we used the age groups
defined by these investigators for the analysis
of the immune response, i.e., newborn mice
(up to 2 weeks of age), young mice (up to 6
weeks of age), adult mice (up to 24 weeks of
age), middle-aged mice (up to 48 weeks of
age), old mice (up to 72 weeks of age), and
very old mice (96 weeks of age). Antibody
production up to one year after immunization
with TNP-BSA was investigated in these
groups. The primary responses to TNP or
BSA were quite similar in all animals up to 48
weeks of age, although the older mice (72
weeks of age) presented significantly reduced
antibody levels to both the haptenic and pro-
tein portions of the antigen. Re-challenge with
the antigen rapidly elevated the antibody lev-
els in all experimental groups. Interestingly,
neonate animals (2 weeks of age) had interme-
diate antibody levels compared to those ob-
served in the sera of old and adult animals for
both the primary and secondary responses.
These results indicate that the immune system
of young and old animals displays the same
functioning pattern, although at different lev-
els of antibody response, with old mice (72
weeks of age) being less responsive to the
antigen after both primary and secondary im-
munization. These results may reflect a more
limited repertoire in the older individuals rather
than a reduced response capacity (14,35,36).
Alternatively, the lower antibody levels ob-
served in the older mice may reflect alterations
in T cell function, as suggested by several
investigators (for reviews, see Refs. 7,37,38).
To test the latter hypothesis, we carried
out experiments to determine mitogen-in-
duced T lymphocyte proliferation in spleen
cells from naive and immunized mice of
different ages. Confirming our assumptions,
age-related changes in mitogen-induced pro-
liferation were observed for the T cells of
both naive and immunized mice, with the
youngest (2 and 4 weeks) and oldest (48 and
72 weeks) being the least responsive to Con-
A. Moreover, cells from immunized mice
were more responsive to Con-A than cells
from naive mice. However, these results
seem to be more related to the administra-
tion of the adjuvant than to antigen immuni-
zation since the mice that received only FCA
displayed results similar to those observed
in mice that received the antigen plus the
adjuvant. Also, we have observed in our
laboratory that antigen-specific proliferation
does not change significantly with aging in
immunized mice (data not shown).
Studies carried out by Cakman et al. (22)
showed that dysregulation in T helper cell
subpopulations may contribute to the down-
regulation of the antibody response, as indi-
cated by the production of low affinity anti-
bodies and auto-antibodies instead of anti-
gen-driven ones in elderly subjects. Here,
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we also observed significant changes in TH1
and TH2 cytokine levels in the supernatants
of Con-A-stimulated spleen cells with ad-
vancing age. IL-2 and IFN-γ, for example,
were present at higher concentrations in the
supernatants of spleen cells from younger
mice (16 and 32 weeks of age). The present
data agree with earlier studies describing a
decrease in IL-2 production related to aging
(16,28,38), although some reports have
shown no significant changes or even an
increase in IL-2 expression in response to
mitogenic stimulation in older humans and
rodents (for reviews, see Ref. 7).
Age-related changes in the capacity to
respond to mitogens and to produce TH2
cytokines have also been the subject of con-
troversy in the literature (for reviews, see
Refs. 7,15,16). Some investigators have
shown an increase in IL-4 levels in mitogen-
stimulated cells (for reviews, see Refs. 15,
17,19) while others have detected a decrease
in IL-4 synthesis in mitogen-stimulated
spleen cells in aged experimental models
(for reviews, see Refs. 15,39). Here, we
observed that the levels of IL-4 and IL-10
increased progressively in the supernatant
of Con-A-stimulated T cells from naive mice
2 to 32 weeks of age, and were significantly
lower than those in the supernatants of spleen
cells from older mice. Fourteen days after
primary immunization, the levels of these
cytokines were significantly increased in the
T cell cultures from all age groups, in con-
trast to what was observed from non-immu-
nized or boosted mice. Thus, our results
showed that T cells from young mice were
more efficient in the production of both TH1
and TH2 cytokines than were those from
older mice. In addition, the TH1 and TH2
cytokine kinetics were distinct since TH1
levels were maintained for long periods of
time after immunization, while those of TH2
cytokines decreased rapidly. However, the
oldest mice sustained the production of TH2
cytokines for a longer period of time after
immunization.
Previous reports have shown that age-
dependent changes in T cell behavior may
be a consequence of thymus involution and
consist of a gradual decrease in number of
cells, with an increase in the CD4+/CD8+
ratio due to the relative reduction in the
number of CD8+ T cells (24). However,
other studies have found a decrease in CD4/
CD8 ratio in mice as they aged, reflecting a
significant decrease on CD4+ T cell numbers
and only a slight decrease in CD8 T cells
(20). Studies on human beings have shown
that the percentage of CD4+ T cells does not
vary throughout their lifetime, although CD8+
T cells suffer a decrease in number and
density of surface molecules, probably con-
tributing to a reduction in host defenses
against viral infections (24,40). Our results
partially agree with those reported in the
literature, i.e., the percentage of CD3+CD4+
and CD3+CD8+ cells increased up to 8 weeks
of age, and the CD4/CD8 cell ratio did not
change significantly with aging.
We consider the aging process to be re-
sponsible for changes in the immune system
that result in differentiated immune responses
in younger and older animals, but this does not
necessarily mean that these responses are in-
sufficient for the maintenance of homeostasis
in the elderly. However, our results have also
shown that the immune system of older indi-
viduals is less responsive to new antigens, as
shown by the low levels of antibodies gener-
ated against exogenous proteins. Perhaps, a
limited repertoire of lymphocytes may leave
old subjects less prepared to deal with newly
encountered infectious agents or altered self-
antigens, thus leading to the greater suscepti-
bility of the elderly to infections and cancer.
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